Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

被引：9
|
作者：
Langabeer, Stephen E. [1 ]
McCarron, Sarah L.
Carroll, Peig
Kelly, Johanna [2 ]
O'Dwyer, Michael [3 ]
Conneally, Eibhlin [4 ]
机构：
[1] St James Hosp, Cent Pathol Lab, Dublin 8, Ireland
[2] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin, Ireland
[3] Natl Univ Ireland, Dept Haematol, Galway, Ireland
[4] St James Hosp, Dept Haematol, Dublin 8, Ireland
来源：
LEUKEMIA RESEARCH | 2011年 / 35卷 / 09期
关键词：
IMATINIB; MUTATION; DISEASE;
D O I：
10.1016/j.leukres.2011.05.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E169 / E170
页数：2
相关论文
共 50 条
  • [1] Molecular Response of e19a2 BCR-ABL1 Chronic Myeloid Leukemia With Double Philadelphia Chromosome to Dasatinib
    Ikeda, Kazuhiko
    Harada-Shirado, Kayo
    Matsumoto, Hayato
    Noji, Hideyoshi
    Ogawa, Kazuei
    Takeishi, Yasuchika
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) : E130 - E133
  • [2] Variant e19a2 BCR-ABL1 Fusion Transcript in Typical Chronic Myeloid Leukemia
    Tutulan-Cunita, Andreea Cristina
    Chirieac, Sorina Mihaela
    Mocanu, Gabriela
    Luca, Catalina
    Costache, Marieta
    Lungeanu, Agripina
    Arghir, Aurora
    CLINICAL LABORATORY, 2011, 57 (9-10) : 785 - 788
  • [3] Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India
    Sazawal, Sudha
    Chikkara, Sunita
    Singh, Kanwaljeet
    Chaubey, Rekha
    Chandra, Dinesh
    Mishra, Pravas
    Mahapatra, Manoranjan
    Seth, Tulika
    Saxena, Renu
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 27 : 24 - 27
  • [4] Chronic myeloid leukemia with variant e19a2 BCR-ABL1 fusion transcript: interest of the molecular identification at diagnosis for minimal residual disease follow-up
    Gendron, Nicolas
    Belhouachi, Nabila
    Morel, Veronique
    Azgui, Zahia
    Maloum, Karim
    Florence Nguyen-Khac
    Cayuela, Jean-Michel
    Davi, Frederic
    Merle-Beral, Helene
    Chapiro, Elise
    ANNALES DE BIOLOGIE CLINIQUE, 2014, 72 (03) : 359 - 366
  • [5] A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib
    Cea, Michele
    Cirmena, Gabriella
    Garuti, Anna
    Rocco, Ilaria
    Palermo, Claudia
    Cagnetta, Antonia
    Moran, Eva
    Colombo, Nicoletta
    Grasso, Raffaella
    Fugazza, Giuseppina
    Gobbi, Marco
    Nencioni, Alessio
    Ballestrero, Alberto
    Patrone, Franco
    LEUKEMIA RESEARCH, 2010, 34 (09) : E240 - E242
  • [6] Molecular Response to Nilotinib in a Patient with Imatinib-intolerant e19a2-positive Chronic Myeloid Leukemia
    Kajiguchi, Tomohiro
    Okuno, Shingo
    Ohno, Toshihito
    Abe, Akihiro
    INTERNAL MEDICINE, 2014, 53 (24) : 2801 - 2804
  • [7] Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia
    Krumbholz, Manuela
    Karl, Matthias
    Tauer, Josephine T.
    Thiede, Christian
    Rascher, Wolfgang
    Suttorp, Meinolf
    Metzler, Markus
    GENES CHROMOSOMES & CANCER, 2012, 51 (11) : 1045 - 1053
  • [8] First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts
    Andrikovics, Hajnalka
    Nahajevszky, Sarolta
    Szilvasi, Aniko
    Bors, Andras
    Adam, Emma
    Kozma, Andras
    Kajtar, Bela
    Barta, Aniko
    Poros, Anna
    Tordai, Attila
    HEMATOLOGICAL ONCOLOGY, 2007, 25 (03) : 143 - 147
  • [9] Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes
    Stuckey, Ruth
    Casado, Luis-Felipe
    Colomer, Dolors
    Teresa Gomez-Casares, Maria
    Casas, Laura
    Garcia-Gutierrez, Valentin
    Luis Sastre, Jose
    Ramirez-Payer, Angel
    Vall-Llovera, Ferran
    Angeles Goni, Maria
    Xicoy, Blanca
    Cristina Godoy, Ana
    Nunez, Javier
    Mora, Itxaso
    Vallansot, Rolando
    Luis Lopez-Lorenzo, Jose
    Palomera, Luis
    Conesa, Venancio
    Soledad Noya, Maria
    Sanchez-Guijo, Fermin
    Pena, Ascension
    Bautista, Guiomar
    Luis Steegmann, Juan
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (10) : 1217 - 1224
  • [10] A rare e9a1 BCR-ABL1 fusion transcript in chronic myeloid leukemia
    Miao, Y.
    Huang, Y.
    Feng, C.
    Jiang, L.
    Xu, H.
    Chen, Z.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (01) : E14 - E16
12345